Global NewsNews

Endo Tools Therapeutics announces US Commercial cases of Endomina System

The endomina system, a new suturing tool for endoscopists, is designed to enable less invasive procedures and expand treatment options for more patients 

Endo Tools Therapeutics (ETT), developers of advanced endoscopic medical devices, announced first US commercial cases of the endomina system. The system is designed for endoscopic placement of suture(s) and approximation of soft tissue in the gastrointestinal tract. The first endomina procedures were performed by Dr Chris Thompson and Dr Pichamol Jirapinyo at Brigham and Women’s Hospital in Boston, MA.

“We are thrilled to be the first hospital in the US to perform gastric procedures using the endomina system. The system offers a minimally invasive option with a large working space to approximate very large plications,” said Dr Thompson. “I look forward to incorporating endomina into my daily practice, as I found it particularly easy to learn and use due to its unique design.”

The endomina system consists of a triangulation platform and suturing units (TAPES). It can be affixed to various tested standard endoscopes, providing a bendable therapeutic channel that can move independently. Physicians will be able to perform suturing like a laparoscopic intervention but through a natural orifice, the mouth. The endomina system is the only technology that can be assembled on the endoscope in the stomach for a greater working space and easy introduction of instruments into the esophagus.

“We are delighted the endomina system is now available to patients and physicians in the U.S. market,” said Alexandre Chau, CEO, Endo Tools Therapeutics. “The successful completion of these first cases in the US demonstrates the potential for this technology to improve the lives of patients undergoing gastric surgery.”

The endomina system is CE marked and has received 510k clearance in the US. More than 500 procedures have already been performed with the company’s devices globally.

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Back to top button
IndiaMedToday
Close
Close